期刊文献+

用HPLC-MS/MS法测定人尿液中依普利酮的浓度

Determination of eplerenone concentration in human urine by HPLC-MS/MS method
下载PDF
导出
摘要 目的:建立HPLC-MS/MS法测定人尿液中依普利酮的浓度。方法:用蛋白质沉淀法处理尿液,采用Waters Symmetry C18色谱柱(50 mm×4.6 mm,5μm),流动相为甲醇(A)-乙腈(B)-1 mmol/L乙酸铵水溶液(C),梯度洗脱(0.01min:15%A,85%C;0.8min:100%A;2.1min 50%A,50%B;2.11~3.5min:15%A,85%C);流速:1.0ml/min,柱温:40℃,采用电喷雾离子源,正离子扫描模式检测。考察该方法的专属性、标准曲线、定量下限、精密度、回收率、基质效应和稳定性。结果:依普利酮尿液浓度在5~2000ng/ml范围内线性关系良好(r>0.996 8),定量下限为5ng/ml。批内精密度RSD<4.31%,批间精密度RSD<6.69%,提取回收率在94.41%~98.47%,基质效应在83.97%~99.22%(n=6)。结论:该法准确、灵敏,重复性好,可用于依普利酮在人尿液中浓度的测定。 Objective:To establish a HPLC-MS/MS method for concentration determination of eplerenone in human urine.Methods:The urine was treated by protein precipitation.Waters Symmetry C18 column(50 mm×4.6 mm,5μm)was employed with the mobile phase consisting of methanol(A)-acetonitrile(B)-1 mmol/L ammonium acetate solution(C),gradient elution(0.01 min,15% phase A,85% phase C;0.8 min,100% phase A;2.1 min,50% phase A,50% phase B;2.11-3.5 min,15%phase A,85% phase C)at a flow rate of 1.0 ml/min.The column temperature was 40 ℃.Mass spectrometry was performed using electro spray ionization(ESI),combined with positive ion scanning switch.A comprehensive investigation was made on the specificity,standard curve,lower limit of quantitation,precision,recovery rate,matrix effect and stability of the substance.Results:A good linearity(r=0.996 8)of eplerenone was obtained in the concentrations range of 5-2000 ng/ml,with the lower limit of quantitation of 5 ng/ml.The rates of intra-and inter-batch precision were less than 4.31% and 6.69%,respectively.The extraction recovery rate ranged from 94.41%to 98.47%,and matrix effect was within the range of 83.97%-99.22%(n=6).Conclusion:The method was accurate,sensitive,reproducible,and could be used for the determination of eplerenone in human urine.
出处 《药学服务与研究》 CAS 2018年第1期29-32,共4页 Pharmaceutical Care and Research
关键词 依普利酮 含量测定 尿 色谱法 高效液相 质谱法 药代动力学 eplerenone concentration determination urine chromatography,high performance liquid spectrometry pharmacokinetics
  • 相关文献

参考文献7

二级参考文献31

  • 1黄震华.选择性醛甾酮拮抗药在高血压治疗中的应用[J].中国新药与临床杂志,2006,25(2):136-139. 被引量:9
  • 2邹晓华,冯友根.新一代醛固酮拮抗剂依普利酮[J].中国医院药学杂志,2006,26(10):1286-1288. 被引量:3
  • 3ZHANG JY, FAST DM, BREAU AP. A validated SPE-LC-MS/ MS assay for eplerenone and its hydrolyzed metabolite in human urine [J]. J Pharma Biomed Anal, 2003, 31 (1): 103-115.
  • 4Davis KL, Nappi JM. The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonist [J]. Clin Ther, 2003, 25: 2647-2668.
  • 5Zhang JY, Fast DM, Breau AE Development and validation of a liquid chromatography-tandem mass spectrometric assay for eplerenone and its hydrolyzed metabolite in human plasma [J]. J Chromatogr B, 2003, 787: 333-344.
  • 6Cook CS, Zhang LM. lnterconversion pharmacokinetics of eplerenone, a selective aldosterone blocker, and its lactonering open form [J]. J Pharm Sci, 2002, 91:1383-1389.
  • 7Cook CS, Berry LM, Bible RH. Pharmacokinetics and metabolism of [14C]eplerenone after oral administration to humans [J]. Drug Metab Dispos, 2003, 31: 1448-1455.
  • 8Ravis WR, Reid S, Sica DA, et al. Pharmacokinetics of eplerenone after single and multiple dosing in subjects with and without renal impairment [J]. J Clin Pharmacol, 2005, 45 810-821.
  • 9Meineke I, Gleiter CH. Assessment of drug accumulation in the evaluation of pharmacokinetic data [J]. J Clin Pharmacol, 1998, 38: 680-684.
  • 10Ding L, Li L, Ma PC. Determination of azelnidipine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry [J]. J Pharm Biomed Anal, 2007, 43: 575-579.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部